Zhejiang Anglikang Pharmaceutical Hits Day Low Amid Price Pressure at CNY 36.98

Zhejiang Anglikang Pharmaceutical Co. experienced significant market activity on May 25, 2026, with the stock declining by 10.0% and reaching an intraday low of CNY 36.98. This performance stands in contrast to the China Shanghai Composite, which gained 0.96% on the same day. Over the past week, Zhejiang Anglikang has seen a decline of 11.85%, while its one-month performance shows a decrease of 7.32%. Despite these short-term challenges, the company has demonstrated a remarkable annual return of 160.42%, significantly outperforming the broader market's 24.02% increase. Financial metrics reveal a mixed picture for the mid-cap pharmaceutical firm. The company has a market capitalization of CNY 8,009 million and a price-to-earnings ratio of 42.00. However, its return on equity stands at 9.35%, and the price-to-book ratio is notably high at 4.87. Additionally, while the stock has a dividend yield of 0.57%, net sales growth has been modest at an annual rate of 3.31%, with operating profit declining by 6.58% over the last five years.